At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Prostate cancer radiotherapy using real-time trackingradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase I Feasibility Study of Prostate Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator Adaptation and Radiofrequency Tracking (Calypso)
In Brief
A clinical study evaluating Prostate cancer radiotherapy using real-time tracking for Prostate Cancer. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to monitor movement of the prostate during radiotherapy and adjust the radiation beam to account for any motion seen. This will increase the radiation dose to the prostate and decrease the dose to the rectum and bladder.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesAustralia
CollaboratorsUniversity of Sydney
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
First PostedJan 2014
Primary CompletionFeb 2018
TodayJul 2026
First PostedJan 10, 2014
Enrollment StartOct 1, 2013
Primary CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 12.5 years ago
Interventions
Prostate cancer radiotherapy using real-time trackingradiation
Radiotherapy delivered using Calypso radiofrequency emitting beacon guided real-time prostate localisation and beam adjustment using Dynamic Multi-leaf Collimator tracking software.